Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection
Background. Hepatitis C is a leading cause of mortality among HIV-infected individuals. Therefore, eradication of HCV in this population is a priority. There are scarce data regarding retreatment efficacy of HIV/ HCV coinfected patients. The aim of our study was to evaluate efficacy, predictors of r...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2013-03-01
|
| Serier: | Annals of Hepatology |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S1665268119313614 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
